Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
Clean energy, efficient tech, thoughtful siting, and community input can curb data centers’ environmental and social impacts.
Faculty
ERM part-time lecturer Rajat Baijal breaks down the lessons for risk management from the fall of hedge fund Situational Awareness.
Faculty
Sustainability education is crucial for preparing professionals to advance practical environmental solutions amid uncertainty.
All News
